| Title |
Author |
Type |
Date |
Words |
| Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer. |
|
|
Apr 16, 2021 |
191 |
| Synthetic Biologics doses first patient in Phase 1b/2a trial of aGVHD candidate. |
|
|
Apr 14, 2021 |
201 |
| 'Speed up NHS access to new MS treatment'. |
MARK SMITH Health correspondent mark.smith@walesonline.co.uk |
|
Apr 1, 2021 |
647 |
| I got my life back ... now let's help other MS sufferers do the same; WOMAN BACKS GROWING CALLS FOR FUNDING OF STEM CELL TRANSPLANT TREATMENT IN WALES. |
STEVE BAGNALL Daily Post Reporter steve.bagnall@reachplc.com |
|
Apr 1, 2021 |
686 |
| HSC Transplants In Embryos Open Door For Hematopolesis Research. |
|
|
Mar 29, 2021 |
414 |
| CTI BioPharma says pacritinib shows 'encouraging' clinical benefit in Phase 1. |
|
|
Mar 22, 2021 |
240 |
| Factors Affecting Mortality in Hematology Patients Accepted to the Intensive Care Unit. |
Talan, Leyla; Altintas, Neriman Defne |
Report |
Mar 18, 2021 |
3022 |
| Atara Biotherapeutics presents long-term OS data from Phase 2 Tab-cel studies. |
|
|
Mar 14, 2021 |
322 |
| ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA; A SINGLE CENTRE EXPERIENCE. |
Tariq Azam Khattak, Muhammad Farhan, Tariq Ghafoor, Tariq Mahmood Satti, Qamar Un Nisa Chaudhry and |
|
Feb 28, 2021 |
3087 |
| Stifel GMP boosts target price of Medexus by 130%, saying Treosulfan could double company valuation. |
|
|
Feb 25, 2021 |
419 |
| Increase in people wanting to donate blood stem cells. |
EMMA MORRICE |
|
Feb 16, 2021 |
482 |
| Medexus Pharmaceuticals strikes licensing agreement to commercialize treosulfan in the US. |
|
|
Feb 3, 2021 |
756 |
| NA Proactive news snapshot:AaMedexus Pharmaceuticals, Kwesst Micro Systems, Ximen Mining, PyroGenesis Canada, Biocept, BioSig UPDATE... |
|
|
Feb 3, 2021 |
3992 |
| Blood Stem Cell Transplants May Provide Long-Term Benefit For MS Patients. |
|
|
Feb 1, 2021 |
529 |
| Scientists Discover New. Pathway Essential For Blood Formation. |
|
|
Feb 1, 2021 |
249 |
| Vaccine-preventable infection risk high for pediatric HCT recipients. |
Lodge, Anna |
|
Feb 1, 2021 |
432 |
| Overlooked Prophylaxis of Hepatitis B in Patients Undergoing Hematopoietic Stem Cell Transplantation. |
Ture, Zeynep; Unuvar, Gamze Kalin; Kahveci, Huseyin Nadir; Keklik, Muzafer; Kilic, Aysegul Ulu |
Report |
Jan 19, 2021 |
4009 |
| China National Medical Products Administration Approves EdiGene IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in I[superscript two]-thalassemia. |
|
|
Jan 19, 2021 |
455 |
| Transferring Aged Hematopoietic SCs To Young Bone Marrpw Spurs Rejuvenation. |
|
|
Jan 18, 2021 |
393 |
| US FDA Clears Vor's IND Application for VOR33. |
|
|
Jan 14, 2021 |
375 |
| Clinical Course of COVID-19 in a Thalassemia Major Patient who Underwent Haematopoietic Stem Cell Transplantation/Hematopoetik Kok Hucre Nakli Yapilmis Bir Talasemi Major Hastasmda COVID-19'un Klinik Seyri. |
Hamidi, Aziz Ahmad; Ulu, Yildiz; Aktac, Habibullah |
Clinical report |
Jan 1, 2021 |
1713 |
| ALTERED APOPTOTIC PROTEIN EXPRESSIONS CHARACTERIZE THE SURVIVAL OF BCR-ABL-INDEPENDENT DRUG-RESISTANT CHRONIC MYELOID LEUKEMIA CELL LINE. |
Baykal-Kose, Seda; Yalcin, Pelin |
|
Jan 1, 2021 |
2406 |
| New method found to boost supply of life-saving stem cells. |
Daily News Egypt |
|
Dec 9, 2020 |
526 |
| How do you donate stem cells? Donating cells can help treat cancer, blindness and other conditions - here's how; A new stem cell treatment could restore eyesight in some people. |
Jenna Macfarlane |
|
Dec 4, 2020 |
717 |
| Pluristem To Present Initial Results From Phase 1 HCT Study. |
|
|
Nov 30, 2020 |
318 |
| Repetitive Elements Trigger RIG-I-Like Receptors. |
|
|
Nov 30, 2020 |
189 |
| Omeros Submits its Biologics License Application to US FDA for Narsoplimab in HSCT-TMA. |
|
|
Nov 18, 2020 |
740 |
| FDA Grants RMAT Status To Vascular Injury Therapy For SC Transplant Patients. |
|
|
Nov 16, 2020 |
274 |
| TaiGen Partners with GPCR to develop Burixafor and Taigexyn(R). |
|
|
Nov 9, 2020 |
383 |
| Sanofi To Buy Dutch Biopharmaceutical Firm Kiadis For EUR308 Million. |
|
|
Nov 2, 2020 |
175 |
| Researchers Find A Way To Make Cancer Stem Cells Vulnerable: Potential Treatment For Leukemia? |
|
|
Nov 2, 2020 |
584 |
| Pluristem Cleared To Enroll More Patients In Phase 1/2 GvHD Study. |
|
|
Nov 2, 2020 |
216 |
| A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure. |
Zhu, Bing; You, Shaoli; Rong, Yihui; Yu, Qiang; Lv, Sa; Song, Fangjiao; Liu, Hongling; Wang, Huaming |
|
Nov 1, 2020 |
5308 |
| Forma Tpresents data from a planned interim analysis of olutasidenib,. |
|
|
Oct 26, 2020 |
256 |
| Omeros reports final efficacy data from narsoplimab pivotal trial in HSCT-TMA. |
|
|
Oct 22, 2020 |
264 |
| AlloVir to present health outcomes analyses at IDWeek 2020. |
|
|
Oct 21, 2020 |
702 |
| Pluristem announces clearance for enrollment of Cohort II in GvHD study. |
|
|
Oct 13, 2020 |
251 |
| Gamida Cell and Be The Match BioTherapies expand strategic collaboration. |
|
|
Oct 13, 2020 |
205 |
| Army civilian donates cells to leukemia patient. |
|
|
Oct 7, 2020 |
297 |
| Vor Biopharma, Arbor Biotechnologies to Collaborate on Engineered Hematopoietic Stem-Cell Therapies. |
|
|
Sep 30, 2020 |
324 |
| Avrobio gets orphan drug designation from the EC for AVR-RD-02. |
|
|
Sep 28, 2020 |
245 |
| Avrobio Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease. |
|
|
Sep 28, 2020 |
476 |
| Mustang Bio announces Orphan Drug Designation for MB-207. |
|
|
Sep 22, 2020 |
370 |
| First Patient.Dosed In Clinical Trial Evaluating NK Cells In COVID-19 Patients. |
|
|
Sep 21, 2020 |
480 |
| Celularity doses first COVID-19 patient in Phase I/II study of human placental hematopoietic stem cell derived NK cells. |
|
|
Sep 9, 2020 |
284 |
| Celularity doses first COVID-19 patient in Phase I/II study of human placental hematopoietic stem cell derived NK cells. |
|
|
Sep 9, 2020 |
288 |
| Celularity Activates California Clinical Trial of COVID-19 Treatment: Move Follows CIRM Grant Award. |
|
|
Sep 7, 2020 |
579 |
| The Use of Bone Marrow--Derived Stem Cells in the Treatment of a Comminuted Tibiotarsal Fracture in a Juvenile Red-legged Seriema (Cariama cristata). |
Pereira, Vitoria M.; Roballo, Kelly C.S.; Silva, Andre N.E.; Cordeiro, Jefferson F.; Bressan, Thais |
Report |
Sep 1, 2020 |
3577 |
| Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Acute Radiation Syndrome. |
Qian, Liren; Cen, Jian |
|
Aug 31, 2020 |
8476 |
| Mustang Bio announces Rare Pediatric Disease Designation for MB-207. |
|
|
Aug 31, 2020 |
319 |
| Temporal Change in Blood Group after Bone Marrow Transplant: A Case of Successful ABO-Incompatible Deceased Donor Transplant. |
Lam, Susanna; Hultin, Sebastian; Preston, John; Campbell, Scott |
|
Aug 31, 2020 |
2896 |
| Emergency Combination of Four Drugs for Bloodstream Infection Caused by Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients with Hematologic Malignancies after Hematopoietic Stem Cell Transplantation. |
Li, Xiaofan; Hong, Yaqun; Chen, Xianling; Chen, Ping; Li, Nainong |
|
Aug 31, 2020 |
5051 |
| BioLineRx achieves enrollment target in Phase 3 GENESIS trial. |
|
|
Aug 19, 2020 |
160 |
| Pluristem completes patient enrollment in Phase I study of PLX-R18. |
|
|
Aug 19, 2020 |
189 |
| DCRC storing cord blood stem cells. |
|
|
Aug 11, 2020 |
341 |
| Celularity awarded USD750,000 CIRM grant to advance COVID-19 treatment in California. |
|
|
Aug 6, 2020 |
237 |
| Celularity awarded USD750,000 CIRM grant to advance COVID-19 treatment in California. |
|
|
Aug 6, 2020 |
241 |
| The First Asian, Single-Center Experience of Blastocyst Preimplantation Genetic Diagnosis with HLA Matching in Thailand for the Prevention of Thalassemia and Subsequent Curative Hematopoietic Stem Cell Transplantation of Twelve Affected Siblings. |
Tiewsiri, Kasorn; Manipalviratn, Somjate; Sutheesophon, Warachaya; Vanichsetakul, Preeda; Thaijaroen |
Report |
Jul 31, 2020 |
8169 |
| Orchard Therapeutics, GSK enter license agreements for stable cell line tech. |
|
|
Jul 15, 2020 |
195 |
| Orchard Therapeutics, MolMed extend collaboration for five years. |
|
|
Jul 9, 2020 |
173 |
| Cord Blood Stem Cell Transplants Outperform "Gold Standard" Matched Siblings--Study. |
|
|
Jun 29, 2020 |
495 |
| Magenta Therapeutics, NMDP announce clinical collaboration for MGTA-145. |
|
|
Jun 11, 2020 |
233 |
| Magenta Therapeutics to discontinue enrollment in Phase 2 study in IMDs. |
|
|
Jun 11, 2020 |
404 |
| Electronic registration system for cord blood stem cells launched. |
Staff Report |
|
Jun 4, 2020 |
345 |
| Mobilized Stem Cells Shown Effective In Gene Therapy. |
|
|
Jun 1, 2020 |
556 |
| Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients. |
Jeong, Chaiho; Kim, Hee-Je; Lee, Seok; Kang, Moo Il; Ha, Jeonghoon |
|
May 31, 2020 |
4136 |
| The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients. |
Yegin, Zeynep Arzu; Can, Ferda; Gokcen, Sanem; Sadioglu, Rezzan Eren; Ozkurt, Zubeyde Nur; Ilhan, Ci |
|
May 28, 2020 |
4203 |
| Jazz Pharmaceuticals stops enrollment in Phase 3 study of defibrotide. |
|
|
Apr 29, 2020 |
239 |
| Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe. |
|
|
Apr 22, 2020 |
337 |
| Posttransplantation Lymphoproliferative Disease Treated by Retransplantation. |
Abrahamsen, Ingerid Weum; Gronvold, Bjorn Christer; Inderberg, Else Marit; Mensali, Nadia; Mattsson, |
|
Mar 31, 2020 |
2186 |
| Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases. |
Sarwar, Mariam; Gardezi, Syed Adeel Hussain; Zaman, Gohar; Ikram, Aamer; Sattia, Luqman; Khadim, Muh |
Report |
Mar 31, 2020 |
1570 |
| Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax. |
Jehangir, Waqas; Karabachev, Alexander; Jahangir, Taimoor; Umyarova, Elvira |
|
Mar 31, 2020 |
2201 |
| Comparison of Haemonetics MCS Plus and Baxter CS 3000 Plus for Platelet Apheresis: Experience at a Tertiary Care Hospital. |
Asma Saadia, Tahir Naeem, Saad Jamal-ud-Din Alvi, Majid Ali and Toqeer Ali Butt |
|
Mar 31, 2020 |
2984 |
| AlloVir's Viralym-M Granted Orphan Drug Designation by European Medicines. |
|
|
Mar 30, 2020 |
797 |
| Blood Stem Cells Boost Immunity By Keeping A Record Of Previous Infections. |
|
|
Mar 23, 2020 |
569 |
| Forty Seven, Rocket Pharmaceuticals announces research collaboration. |
|
|
Mar 11, 2020 |
264 |
| A retrospective description of primary immunodeficiency diseases at Red Cross War Memorial Children's Hospital, Cape Town, South Africa, 1975-2017. |
Moodley, S.; Goddard, E.; Levin, M.; Scott, C.; van Eyssen, A.; Davidson, A.; De Decker, R.; Wilmshu |
|
Mar 1, 2020 |
5179 |
| Evaluation of Drug-Related Problems in a Pediatric Bone Marrow Transplantation Unit Identified by a Clinical Pharmacist in-training in a 7-Month Period. |
Ozdemir, Nesligul; Celiker, Ayce; Kuskonmaz, Bulent Bans; Okur, Fatma Visal; Cetinkaya, Duygu Uckan |
|
Mar 1, 2020 |
4177 |
| Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature. |
Gandhi, S.; Behling, E.; Behrens, D.; Ferber, A.; Schwarting, R.; Budak-Alpdogan, T. |
|
Mar 1, 2020 |
4379 |
| Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis. |
Agrawal, Vaibhav; Brinda, Bryan J.; Farag, Sherif S. |
|
Mar 1, 2020 |
4038 |
| Network Pharmacology-Based Investigation of the System-Level Molecular Mechanisms of the Hematopoietic Activity of Samul-Tang, a Traditional Korean Herbal Formula. |
Lee, Ho-Sung; Lee, In-Hee; Park, Sang-In; Lee, Dae-Yeon |
|
Mar 1, 2020 |
11165 |
| 'Donating bone marrow was painful, but it's so rewarding I'd do it all again tomorrow'. |
simon thomas Sports reporter simon.thomas@walesonline.co.uk |
|
Feb 21, 2020 |
1235 |
| 'I'd love to meet the young man to whom I gave the gift of life' Two years ago a selfless popular Welsh rugby player risked his career to save a life. Simon Thomas reports WM2 Agenda Letters Opinion 'My whole brain was covered in blood... I was in so much pain' Page 24. |
|
|
Feb 21, 2020 |
1187 |
| Assessment of Post-transplantation Liver Function Tests in Patients Undergoing Allogeneic Stem Cell Transplantation. |
Kiziltepe, Melih; Yildizhan, Esra; Unal, Ali; Cetin, Mustafa; Eser, Bulent; Kaynar, Leylagul |
|
Feb 13, 2020 |
4790 |
| FDA Clears IND For Allogeneic Cryopreservea NK Cell Therapy. |
|
|
Feb 10, 2020 |
257 |
| How Rogue Communications Between Cells Lead To Leukemia. |
|
|
Feb 10, 2020 |
481 |
| Trial Tests Stem Cell Transplantation Versus Best Available Therapy For MS. |
|
|
Jan 27, 2020 |
342 |
| Cancer Study Finds That One Gene Pushes Stems Cells To Make Blood Stem Cells. |
|
|
Jan 27, 2020 |
650 |
| Seattle announces milestone payment from Roche upon EC's conditional marketing authorisation for Polivy. |
|
|
Jan 22, 2020 |
225 |
| Seattle announces milestone payment from Roche upon EC's conditional marketing authorisation for Polivy. |
|
|
Jan 22, 2020 |
221 |
| European Commission approves Roche's Polivy for people with previously treated aggressive lymphoma. |
|
|
Jan 21, 2020 |
1589 |
| Further Improvements in Survival Seen After Allogeneic Transplant; 2003 to 2017 saw reduction in nonrelapse mortality, relapse of cancer, relapse-related and overall mortality. |
|
|
Jan 21, 2020 |
247 |
| Untreated Oral Infection Not Tied to Stem Cell Transplant Outcomes; Untreated oral infections pretransplant not linked to post-HSCT survival during six-month follow-up. |
|
|
Jan 9, 2020 |
220 |
| Reconstituting blood in humans to be boon for individuals suffering from blood cancer, sickle-cell anaemia: Study. |
ANI |
|
Jan 1, 2020 |
601 |
| 20(S)-Protopanaxdiol Suppresses the Abnormal Granule-Monocyte Differentiation of Hematopoietic Stem Cells in 4T1 Breast Cancer-Bearing Mouse. |
Guo, Wen-Qin; Chen, Ying-Ge; Shi, Rong-Zhen; He, Kai; Wang, Jian- Feng; Shao, Jin-Hui; Wan, Jian-Bo; |
|
Jan 1, 2020 |
6172 |
| Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation. |
Staderini, Michela; Mannelli, Lara; Antonioli, Elisabetta; Puccini, Benedetta; Berti, Valentina; Mun |
|
Jan 1, 2020 |
2862 |
| Successful Treatment of Adenovirus Infection with Brincidofovir in an Immunocompromised Patient after Hematological Stem Cell Transplantation. |
Van Genechten, T.; Van Heerden, J.; Bauters, T.; Dhooge, C. |
|
Jan 1, 2020 |
1233 |
| Secondary Squamous Cell Carcinoma of the Tongue Complicated with Bronchiolitis Obliterans as a Manifestation of Graft-versus-Host Disease following Peripheral Blood Stem Cell Transplantation. |
Hashimoto, Kengo; Nagao, Toru; Koie, Shin; Miyabe, Satoru; Saito, Terumi |
|
Dec 31, 2019 |
2087 |
| Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Do We Treat like an Acute Myeloid Leukemia? |
Pudasainee, Prasun; Pyakuryal, Bimatshu; Subedi, Yogesh; Upadhyay, Jenisha; Adhikari, Subarna |
|
Dec 31, 2019 |
1198 |
| Reactive Oxygen Species and Nrf2: Functional and Transcriptional Regulators of Hematopoiesis. |
Hu, Linping; Zhang, Yawen; Miao, Weimin; Cheng, Tao |
|
Dec 31, 2019 |
8737 |
| Agency Designates GvHD Drug A Breakthrough Therapy. |
|
|
Dec 16, 2019 |
443 |
| ASH: AlloHSCT Feasible After PD-1, PD-L1 mAb in Hodgkin Lymphoma; Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT. |
|
|
Dec 10, 2019 |
258 |
| US FDA grants breakthrough therapy status to Bristol-Myers Squibb's Orencia. |
|
|
Dec 6, 2019 |
190 |
| US FDA grants breakthrough therapy status to Bristol-Myers Squibb's Orencia. |
|
|
Dec 6, 2019 |
186 |
| Omeros Aces Late-Stage Trial Of Transplant Drug Narsoplimab. |
Shanthi Rexaline |
|
Dec 4, 2019 |
350 |
| Study identifies novel risk factors for post-HCT melanoma. |
Worcester, Sharon |
|
Dec 1, 2019 |
422 |
| Unusual Presentation with Orbital Mass in a Child with Precursor B-Cell Acute Lymphoblastic Leukemia. |
Sathitsamitphong, Lalita; Natesirinilkul, Rungrote; Choeyprasert, Worawut; Charoenkwan, Pimlak |
|
Nov 30, 2019 |
1564 |
| Mucormycosis Leading to Cerebral Edema and Cerebellar Tonsillar Herniation after Allogeneic Bone Marrow Transplant: A Case Report. |
Jeurkar, Chetan; Margetich, Lauren; Sahin, Ziver |
|
Nov 30, 2019 |
3203 |
| Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice. |
Rezende, Barbara Maximino; Bernardes, Priscila T.T.; Goncalves, William Antonio; de Resende, Carolin |
|
Nov 30, 2019 |
7844 |
| Vor Biopharma signs clinical and commercial license agreement with MaxCyte. |
|
|
Nov 25, 2019 |
239 |
| Vor Biopharma signs clinical and commercial license agreement with MaxCyte. |
|
|
Nov 25, 2019 |
235 |
| MaxCyte inks licensing deal with cutting-edge US cancer drug developer. |
|
|
Nov 22, 2019 |
216 |
| Oral Mucositis Market Sales Statistics, Growth Projection, Size Estimation and Global Industry Trends and Insights By 2025. |
|
|
Nov 21, 2019 |
825 |
| Transient Wave Of Hematopoietic Stem Cell Production In Late Fetuses And Young Adults. |
|
|
Nov 18, 2019 |
844 |
| NCCCR's surgeons performs 65 life-saving stem cell transplants. |
|
|
Nov 11, 2019 |
493 |
| Many Multiple Sclerosis Patients Considering Stem Cell Transplant; However, many are not well-informed regarding stem cell transplants. |
|
|
Nov 8, 2019 |
238 |
| A consensus document for the clinical management of invasive fungal diseases in pediatric patients with hematologic cancer and/or undergoing hematopoietic stem cell transplantation in Brazilian medical centers. |
Carlesse, Fabianne; Daudt, Liane Esteves; Seber, Adriana; Dutra, Alvaro Pimenta; de Azevedo Melo, An |
|
Nov 1, 2019 |
11419 |
| Bluebird expects to treat the first Zynteglo commercial patient in early 2020. |
|
|
Oct 31, 2019 |
108 |
| Mallinckrodt announces Uvadex receives regulatory approval in Australia. |
|
|
Oct 31, 2019 |
114 |
| A Case of Myeloid Sarcoma following Allogeneic HSCT Presenting as Localized Hip Pain. |
Zhang, Shannon; Charlton, Casey; Amaraneni, Akshay; Maher, Keri |
|
Oct 31, 2019 |
1518 |
| An Unusually Short Latent Period of Therapy-Related Myeloid Neoplasm Harboring a Rare MLL-EP300 Rearrangement: Case Report and Literature Review. |
Takeda, Reina; Yokoyama, Kazuaki; Kobayashi, Seiichiro; Kawamata, Toyotaka; Nakamura, Sousuke; Fukuy |
|
Oct 31, 2019 |
3911 |
| Groundbreaking stem cell therapy for multiple sclerosis recommended for use in Scotland. |
|
|
Oct 30, 2019 |
610 |
| Omeros announces PDCO opinion for narsoplimab. |
|
|
Oct 29, 2019 |
268 |
| US FDA grants orphan-drug designation for AVROBIO's AVR-RD-02. |
|
|
Oct 28, 2019 |
152 |
| US FDA grants orphan-drug designation for AVROBIO's AVR-RD-02. |
|
|
Oct 28, 2019 |
148 |
| Omeros initiates narsoplimab BLA submission. |
|
|
Oct 28, 2019 |
199 |
| Homology Medicines presents investigational PKU gene editing program data. |
|
|
Oct 25, 2019 |
167 |
| Bluebird Bio gets EMA approval for Zynteglo refined manufacturing specifications. |
|
|
Oct 22, 2019 |
133 |
| Plant Compound Added To Gene Therapy May Speed Up Treatments. |
|
|
Oct 21, 2019 |
670 |
| Viagra May Accelerate Restoration Of Stem Cells After Cancer Treatment. |
|
|
Oct 21, 2019 |
872 |
| Stem Cell Banking Market: Opportunities and Challenges. |
|
|
Oct 14, 2019 |
812 |
| Global Cell Therapy Technologies, Companies & Markets During the Forecast Period, 2018-2028. |
|
|
Oct 9, 2019 |
592 |
| Avrobio doses first patient in Phase 1/2 trial of gene therapy for cystinosis. |
|
|
Oct 8, 2019 |
155 |
| Iran Becomes Hub of Cord Blood Stem Cell Storage in Middle East. |
|
|
Oct 6, 2019 |
192 |
| Orchard Therapeutics announces presentation of clinical data for OTL-200. |
|
|
Sep 30, 2019 |
236 |
| Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor. |
Meconi, Federico; Ciangola, Giulia; Mariotti, Benedetta; Cerretti, Raffaella; Cudillo, Laura; Arcese |
|
Sep 30, 2019 |
2405 |
| Designing Microfluidic Devices to Sort Haematopoietic Stem Cells Based on Their Mechanical Properties. |
Du, Mingming; Kavanagh, Dean; Zhang, Zhibing; Kalia, Neena |
|
Sep 30, 2019 |
8405 |
| Stem cells used to treat life-threatening illnesses. |
Staff report |
|
Sep 29, 2019 |
404 |
| Takeda Pharmaceutical announces results of Phase 2 TAK-620 study published. |
|
|
Sep 24, 2019 |
539 |
| Mustang Bio announces City of Hope opens Phase 1 trial of MB-105. |
|
|
Sep 23, 2019 |
272 |
| Gamida Cell and the CIBMTR Collaborate to Advance Research for Cellular Therapy. |
|
|
Sep 13, 2019 |
691 |
| Gamida Cell, CIBMTR announce research agreement for HSTC patient data. |
|
Clinical report |
Sep 11, 2019 |
156 |
| Omeros announces FDA confirms schedule for rolling review of narsoplimab BLA. |
|
|
Sep 11, 2019 |
137 |
| Mikulicz's Disease With Immune Thrombocytopenia: A New Immunoglobulin G4-Mediated Disorder and Literature Review. |
Li, Shu; Deng, Cong; Chen, Jinwei; Li, Fen |
|
Sep 1, 2019 |
2177 |
| Cerebral Involvement of Hemophagocytic Lymphohistiocytosis in Griscelli Syndrome. |
Toret, Ersin; Ay, Yilmaz; Aksoylar, Serap; Karapinar, Tuba Hilkay; Oymak, Yesim |
|
Sep 1, 2019 |
1775 |
| Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients. |
Bellanger, Anne-Pauline; Berceanu, Ana; Scherer, Emeline; Desbrosses, Yohan; Daguindau, Etienne; Roc |
|
Sep 1, 2019 |
1301 |
| Current Advances in Red Blood Cell Generation Using Stem Cells from Diverse Sources. |
Seo, Yoojin; Shin, Kyung-Hwa; Kim, Hyung Hoi; Kim, Hyung-Sik |
|
Aug 31, 2019 |
8254 |
| Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment. |
Bernascon, Paolo; Borsani, Oscar |
|
Aug 31, 2019 |
9846 |
| Artificial Blood Market Product Overview and Significant Growth in forthcoming Year 2019-2026. |
|
|
Aug 22, 2019 |
946 |
| Why Shares Of Micro-Cap Biotech Akari Therapeutics Are Ripping Higher. |
|
|
Aug 14, 2019 |
339 |
| Akari Therapeutics receives FDA Fast Track Designation for nomacopan. |
|
|
Aug 14, 2019 |
207 |
| Mustang Bio announces $9.28M grant to fund Phase 1 trial of MB-103. |
|
|
Aug 13, 2019 |
181 |
| City of Hope Scientist Receives USD 9.28m for CAR T Cell Immunotherapy Clinical Trial for Patients With HER2-Positive Breast Cancer That Has Spread to the Brain. |
|
|
Aug 13, 2019 |
663 |
| CASI Pharmaceuticals Announces Launch of EVOMELAA[R] (melphalan for injection) in China. |
|
|
Aug 12, 2019 |
1098 |
| CRISPR-Cas9 Used To Edit Long-Lived Blood Stem Cells, Reverse Disorder Symptoms. |
|
|
Aug 12, 2019 |
647 |
| Special edition of the SAMJ devoted to cell and gene therapy. |
Pepper, M.S. |
|
Aug 1, 2019 |
1218 |
| Primary immunodeficiency in Africa--a review. |
Erjaee, A.; Bagherpour, M.; van Rooyen, C.; van den Berg, S.; Kinnear, C.J.; PhD; Green, R.J.; Peppe |
|
Aug 1, 2019 |
8400 |
| Heterogeneity of cell therapy products. |
Wolmarans, E.; Mellet, J.; Ambele, M.A.; Durandt, C.; Pepper, M.S. |
|
Aug 1, 2019 |
4986 |
| Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives. |
Grobbelaar, S.; Mercier, A.E.; Verburgh, E.; Brittain, D.; Pepper, M.S. |
|
Aug 1, 2019 |
6981 |
| Transplantation of gene-modified haematopoietic stem cells: Application and clinical considerations. |
Alessandrini, M.; Krause, K.-H.; Speck, R.F.; Pepper, M.S. |
|
Aug 1, 2019 |
5264 |
| Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab. |
|
|
Aug 1, 2019 |
547 |
| Gene Editing for Blood Disorders. |
|
|
Aug 1, 2019 |
729 |
| Global Cell Therapy Technologies, Markets and Companies Research to 2028 with Profiles of 300+ Companies. |
|
|
Jul 31, 2019 |
654 |
| Omeros, Lonza enter long-term manufacturing agreement for narsoplimab. |
|
|
Jul 31, 2019 |
106 |
| Kupffer Cells Promote the Differentiation of Adult Liver Hematopoietic Stem and Progenitor Cells into Lymphocytes via ICAM-1 and LFA-1 Interaction. |
Meng, Deping; Qin, Yuhong; Lu, Nan; Fang, Keke; Hu, Yuan; Tian, Zhigang; Zhang, Cai |
|
Jul 31, 2019 |
9023 |
| Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents. |
Gavriilaki, Maria; Sakellari, Ioanna; Gavriilaki, Eleni; Kimiskidis, Vasilios K.; Anagnostopoulos, A |
|
Jul 31, 2019 |
7016 |
| Iran to Open Center for Hematopoietic Stem Cell Transplantation in Iraq. |
|
|
Jul 28, 2019 |
336 |
| Light Therapy May Prevent Oral Mucositis for Some in Cancer Tx; Laser, other light tx recommended for patients treated with HSCT; head and neck RT with, without chemo. |
|
|
Jul 22, 2019 |
235 |
| Omeros announces agreement with FDA on primary endpoint for narsoplimab trial. |
|
|
Jul 11, 2019 |
287 |
| Family seeks support for young man's treatment. |
|
|
Jul 10, 2019 |
214 |
| Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster; Incidence of herpes zoster decreased during median 21-month follow-up after autologous HSCT. |
|
|
Jul 10, 2019 |
264 |
| Gamida Cell and Lonza to IManufacture Omidubicel. |
|
|
Jul 1, 2019 |
322 |
| Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies. |
Cominal, Jucara Gastaldi; Cacemiro, Maira da Costa; Pinto-Simoes, Belinda; Kolb, Hans-Jochem; Malmeg |
|
Jun 30, 2019 |
7977 |
| Mesenchymal Stem Cell Therapy Overcomes Steroid Resistance in Severe Gastrointestinal Acute Graft-Versus-Host Disease. |
Moritani, Kyoko; Miyawaki, Reiji; Tokuda, Kiriko; Ochi, Fumihiro; Eguchi-Ishimae, Minenori; Tauchi, |
|
Jun 30, 2019 |
3465 |
| Gamida Cell partners with Lonza for the manufacturing and launch of Omidubicel. |
|
|
Jun 19, 2019 |
236 |
| Gamida Cell partners with Lonza for the manufacturing and launch of Omidubicel. |
|
|
Jun 19, 2019 |
232 |
| Gamida Cell, Lonza enter strategic manufacturing agreement. |
|
|
Jun 19, 2019 |
163 |
| Sirion Biotech Licenses Technology to National Institute of Allergy and Infectious Diseases to Boost Clinical Efficacy of Lentivector Gene Therapy for X-Linked SCID. |
|
|
Jun 13, 2019 |
528 |
| Viralym-M Granted Regenerative Medicine Advanced Therapy Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT. |
|
|
Jun 13, 2019 |
691 |
| Rapporteurs Assigned for European Marketing Authorisation Application for Narsoplimab for Treatment of HSCT-TMA. |
|
|
Jun 7, 2019 |
676 |
| The European Commission grants conditional marketing authorisation to bluebird bio's ZYNTEGLO. |
|
|
Jun 5, 2019 |
212 |
| The European Commission grants conditional marketing authorisation to bluebird bio's ZYNTEGLO. |
|
|
Jun 5, 2019 |
208 |
| Bluebird Bio announces EU conditional marketing authorization for ZYNTEGLO. |
|
|
Jun 3, 2019 |
197 |
| CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice. |
Lange, A.P.; Almeida, L.Y.; Silva, C.L. Araujo; Scheucher, P.S.; Chahud, F.; Krause, A.; Bohlander, |
|
Jun 1, 2019 |
3192 |
| Screening molecular markers in various hematological malignancies. |
Akyurek, Esra; Tascioglu, Nazife; Akalin, Hilal; Saatci, Cetin; Ozkul, Yusuf; Ozcan, Alper; Kaynar, |
|
Jun 1, 2019 |
277 |
| Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone. |
Kahkonen, Tiina E.; Suominen, Mari I.; Maki-Jouppila, Jenni H.E.; Halleen, Jussi M.; Tanaka, Azusa; |
|
May 31, 2019 |
6820 |
| Understanding the Journey of Human Hematopoietic Stem Cell Development. |
Kumar, Akhilesh; DSouza, Saritha S.; Thakur, Abir S. |
|
May 31, 2019 |
10688 |
| Magenta Therapeutics Presents Updated Phase 2 Clinical Data on MGTA-456 Cell Therapy at American Academy of Neurology annual meeting. |
|
|
May 15, 2019 |
424 |
| Magenta Therapeutics reveals phase two clinical data of MGTA-456. |
|
|
May 13, 2019 |
134 |
| Magenta Therapeutics reveals phase two clinical data of MGTA-456. |
|
|
May 13, 2019 |
130 |
| Magenta Therapeutics presents updated Phase 2 clinical data on MGTA-456. |
|
|
May 9, 2019 |
408 |
| First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor. |
|
|
May 6, 2019 |
426 |
| Data From Stem Cell Gene Therapy Expansion Program Presented. |
|
|
May 6, 2019 |
312 |
| Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment. |
|
Correction notice |
May 1, 2019 |
177 |
| A Novel Severity Score Index for Febrile Neutropenic Patients with Colorectal Diseases. |
Perazzoli, Camila; Parra, Rogerio S.; Feitosa, Marley R.; Sfoggia, Enrico; Simoes, Belinda Pinto; Ro |
|
Apr 30, 2019 |
3942 |
| Endocarditis following Consumption of Cereal Associated with Salmonella enterica Subtype Mbandaka Outbreak. |
Dickter, Jana K.; Cai, LiYing; Snyder, David S. |
|
Apr 30, 2019 |
3008 |
| The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation. |
Zhang, Jianping; Ren, Guangxu; Li, Minghua; Lu, Peihua; Yi, Suqin |
|
Apr 30, 2019 |
6957 |
| Pneumocystis jirovecii Pneumonia during Brentuximab Vedotin Therapy: A Case Report and Literature Review. |
Ferreira, Aliana Meneses; Ramos, Jessica Fernandes; Fatobene, Giancarlo; Rocha, Vanderson |
|
Apr 30, 2019 |
2118 |
| Acute Leukemia Induces Senescence and Impaired Osteogenic Differentiation in Mesenchymal Stem Cells Endowing Leukemic Cells with Functional Advantages. |
Bonilla, Ximena; Vanegas, Natalia-Del Pilar; Vernot, Jean Paul |
|
Apr 30, 2019 |
9641 |
| First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor. |
|
|
Apr 29, 2019 |
426 |
| First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor. |
|
|
Apr 29, 2019 |
426 |
| First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate. |
|
|
Apr 25, 2019 |
196 |
| 'If I met the girl who saved my life, I'd give her the biggest hug'. |
|
|
Apr 20, 2019 |
697 |
| British patient cured of HIV; MEDICAL MARVELS. |
|
|
Apr 19, 2019 |
173 |
| British patient cured of HIV [...]. |
|
|
Apr 19, 2019 |
173 |
| Aprea Therapeutics passes US FDA Fast Track designation for APR-246 to treat MDS with TP53 mutation. |
|
|
Apr 17, 2019 |
305 |
| Aprea Therapeutics passes US FDA Fast Track designation for APR-246 to treat MDS with TP53 mutation. |
|
|
Apr 17, 2019 |
301 |
| ThermoGenesis Cell Processing Systems Available In Thailand. |
|
|
Apr 15, 2019 |
118 |
| ThermoGenesis Cell Processing Systems Available In Thailand. |
|
|
Apr 15, 2019 |
118 |
| New Strategy For Editing Diseased Blood Stem Cells Is Efficient, Targeted. |
|
|
Apr 8, 2019 |
903 |
| Homology Medicines announces FDA clearance HMI-102 IND. |
|
Clinical report |
Apr 4, 2019 |
254 |
| Omeros announces EBMT case report of resolution of gastrointestinal HSCT-TMA. |
|
|
Apr 3, 2019 |
283 |
| Pacific Biosciences announces retrospective study on PacBio sequencing published. |
|
|
Apr 2, 2019 |
318 |
| bluebird bio Receives Positive Opinion from CHMP for Zynteglo Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent I[superscript two]-Thalassemia Who Do Not Have I[superscript two]0/I[superscript two]0 Genotype. |
|
|
Apr 2, 2019 |
815 |
| Study identifies post-HCT risk factors for skin cancer. |
Rans, Caleb |
|
Apr 1, 2019 |
395 |
| Stem Cells in Cancer Progression and Therapy. |
Tan, Hua; Su, Weijun; Zhang, Xing-Ding |
|
Mar 31, 2019 |
1411 |
| Oxaliplatin Treatment Alters Systemic Immune Responses. |
Stojanovska, Vanesa; Prakash, Monica; McQuade, Rachel; Fraser, Sarah; Apostolopoulos, Vasso; Sakkal, |
|
Mar 31, 2019 |
9890 |
| Bluebird Bio receives positive opinion from CHMP for ZYNTEGLO. |
|
|
Mar 29, 2019 |
160 |
| Breath Therapeutics begins global Phase 3 trials of La[euro]'CsAa[euro]'i for treating Bronchiolitis Obliterans Syndrome. |
|
|
Mar 26, 2019 |
252 |
| Breath Therapeutics begins global Phase 3 trials of La[euro]'CsAa[euro]'i for treating Bronchiolitis Obliterans Syndrome. |
|
|
Mar 26, 2019 |
248 |
| Researchers Discover Gene That Requlates Hematopoietic Stem Cells. |
|
|
Mar 25, 2019 |
467 |
| FDA Approves Trial Of Treatment In Stem Cell Transplant-Related Condition. |
|
|
Mar 25, 2019 |
346 |
| DSMB Approves Enrollment of Final Conort In Phase 1 Hematological Study. |
|
|
Mar 25, 2019 |
382 |
| Magenta Therapeutics declared development candidate in C200 program. |
|
|
Mar 19, 2019 |
113 |
| FDA Approves Trial Of Treatment In Stem Cell Transplant-Related Condition. |
|
|
Mar 18, 2019 |
346 |
| DSMB Approves Enrollment of Final Cohort In Phase 1 Hematological Study: First Two Cohorts Show Primary Safety Endpoint Met, Plus Early Signs Of Efficacy. |
|
|
Mar 18, 2019 |
369 |
| FDA Approves Trial Of Treatment In Stem Cell Transplant-Related Condition. |
|
|
Mar 18, 2019 |
346 |
| DSMB Approves Enrollment of Final Cohort In Phase 1 Hematological Study. |
|
|
Mar 18, 2019 |
382 |
| Pluristem completes enrollment in second cohort of PLX-R18 trial. |
|
|
Mar 12, 2019 |
109 |
| Cellect says third-party study further validates Apograft technology. |
|
|
Mar 11, 2019 |
158 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
460 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
457 |
| HIV hope as man cleared of killer virus. |
|
|
Mar 6, 2019 |
166 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
457 |
| Transplant 'cures' man of HIV virus. |
|
|
Mar 6, 2019 |
113 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| HIV hope as man cleared of virus. |
|
|
Mar 6, 2019 |
462 |
| Man 'cured' of HIV after stem cell transplant. |
|
|
Mar 6, 2019 |
202 |
| Brit is 'cured' of HIV. |
|
|
Mar 6, 2019 |
351 |
| Man is 'cured' of HIV; Virus-free after stem cell swap. |
|
|
Mar 6, 2019 |
360 |
| Tests on London patient offer hope of HIV 'cure'. |
|
|
Mar 5, 2019 |
789 |
| Data Presented On Stem Cell Mobilization Product For Bone Marrow Transplant. |
|
|
Mar 4, 2019 |
258 |
| Data Presented On Stem Cell Mobilization Product For Bone Marrow Transplant. |
|
|
Mar 4, 2019 |
258 |
| Magenta Therapeutics presents preclinical data on targeted conditioning programs. |
|
|
Feb 25, 2019 |
746 |
| Magenta Therapeutics presents data on MGTA-456 cell therapy. |
|
|
Feb 25, 2019 |
919 |
| Chimerix presents results from Phase 3 SUPPRESS trial. |
|
|
Feb 22, 2019 |
247 |
| Vical to discontinue development of VL-2397, to consider strategic options. |
|
|
Feb 19, 2019 |
133 |
| Omeros Streamlines Path to Biologics License Application for OMS721 in HSCT-TMA Following Meeting with FDA. |
|
|
Feb 19, 2019 |
987 |
| Vor Biopharma launches USD42m Series A financing round. |
|
|
Feb 18, 2019 |
192 |
| Vor Biopharma launches USD42m Series A financing round. |
|
|
Feb 18, 2019 |
188 |
| Renewable Source Of Cancer-Fighting T Cells From New Technique. |
|
|
Feb 4, 2019 |
679 |
| Renewable Source Of Cancer-Fighting T Cells From New Technique. |
|
|
Feb 4, 2019 |
585 |
| Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation. |
Atilla, Erden; Atilla, Pinar Ataca; Seval, Guldane Cengiz; Bektas, Mehmet; Demirer, Taner |
Report |
Feb 1, 2019 |
7231 |
| Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation. |
Atilla, Erden; Atilla, Pinar Ataca; Seval, Guldane Cengiz; Bektas, Mehmet; Demirer, Taner |
|
Feb 1, 2019 |
7184 |
| BETA-TALASEMIA: UN MUNDO DE COMPLICACIONES CON NUEVAS ALTERNATIVAS DE TRATAMIENTO. |
Carvajal Alzate, Manuela |
|
Jan 1, 2019 |
6307 |
| Preconditioning with SDF-1 Improves Therapeutic Outcomes of Bone marrow-derived Mesenchymal Stromal Cells in a Mouse Model of STZ-induced Diabetes. |
Farashah, Mohammad Sadegh Gholami; Pasbakhsh, Parichehr; Omidi, Ameneh; Nekoonam, Saied; Aryanpour, |
Report |
Jan 1, 2019 |
4357 |
| Fecal Microbiota Transplantation. |
|
|
Jan 1, 2019 |
430 |
| Clinical and Radiologic Characteristics of Human Metapneumovirus Infections in Adults, South Korea. |
Koo, Hyun Jung; Lee, Han Na; Choi, Sang Ho; Sung, Heungsup; Kim, Hwa Jung; Do, Kyung-Hyun |
|
Jan 1, 2019 |
8161 |
| Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment. |
Hassan, Mohd Nazri; Fauzi, Hafizuddin Mohamed; Husin, Azlan; Mustaffa, Rapiaah; Hassan, Rosline; Ibr |
Report |
Jan 1, 2019 |
6597 |
| CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis. |
Nonino, A.; Nascimento, J.M.; Mascarenhas, C.C.; Mazzeu, J.F.; Pereira, R.W.; Jacomo, R.H. |
Report |
Jan 1, 2019 |
3726 |
| CMV-specific immune system monitoring for management of cytomegalovirus in HSCT. |
Blanchard, Ted; Cruikshank, William |
|
Jan 1, 2019 |
2891 |
| Omeros Seeks European Medicines Nod for Clinical Strategy to Accelerate Pediatric Development of OMS721 for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy. |
|
|
Dec 10, 2018 |
1072 |
| Magenta Therapeutics Presents New Data from Phase 2 Study of MGTA-456 Cell Therapy in Patients with Inherited Metabolic Disorders. |
|
|
Dec 6, 2018 |
527 |
| Omeros submits pediatric investigational plan for use of OMS721 to EMA. |
|
|
Dec 6, 2018 |
439 |
| Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. |
Liu, Jing; Zhao, Xiao-Su; Liu, Yan-Rong; Xu, Lan-Ping; Zhang, Xiao-Hui; Chen, Huan; Chen, Yu-Hong; W |
Report |
Dec 5, 2018 |
5367 |
| CASI Pharmaceuticals wins approval of Melphalan Hydrochloride for Injection in China. |
|
|
Dec 4, 2018 |
250 |
| Gamida Cell publishes data from Phase 1/2 clinical study of NiCord. |
|
Clinical report |
Dec 4, 2018 |
135 |
| Pluristem presents Phase 1 PLX-R18 trial data at ASH. |
|
|
Dec 3, 2018 |
260 |
| Gamida Cell says NiCord recipients demonstrated immune reconstitution in study. |
|
|
Dec 3, 2018 |
393 |
| CASI Pharmaceuticals gets Chinese OK for multiple myeloma drug. |
|
|
Dec 3, 2018 |
268 |
| Magenta presents new data on MGTA-145 stem cell mobilization product candidate. |
|
|
Dec 2, 2018 |
185 |
| Effect of CXCL9-CXCR3 Cytokine Signaling Pathway in Polycytemia Vera/Polisitemia Vera'da CXCL9-CXCR3 Sitokin Sinyal Yolaginin Etkisi. |
Altunay, Cemil; Yavuz, Akif Selim; Tokdemir, Selcuk Sozer |
|
Dec 1, 2018 |
5362 |
| Confounding Case of Hemolysis in a Patient with Acute Leukemia. |
Tesfazghi, Merih T.; Farnsworth, Christopher W.; Roper, Stephen M.; Gronowski, Ann M.; Dietzen, Denn |
|
Dec 1, 2018 |
4141 |
| UPLC-MS/MS Analysis of Urinary Free Oligosaccharides for Lysosomal Storage Diseases: Diagnosis and Potential Treatment Monitoring. |
Huang, Rongrong; Cathey, Sara; Pollard, Laura; Wood, Tim |
Disease/Disorder overview |
Dec 1, 2018 |
4973 |
| Vor Biopharma Issued Foundational US Patent Broadly Covering Compositions and Methods to Treat Hematologic Malignancies. |
|
|
Nov 30, 2018 |
658 |
| Pluristem to present first cohort from PLX-418 study at ASH meeting. |
|
|
Nov 28, 2018 |
200 |
| G1 Therapeutics announces data from phase 2 trilaciclib trial. |
|
|
Nov 26, 2018 |
190 |
| In Vitro Culture and Biological Characteristics of Sheep Amniotic Mesenchymal Stem Cells. |
Lu, Tengfei; Pei, Wenhua; Zhang, Shuang; Wu, Yangnan; Chen, Fenghao; Han, Xiao; Guan, Weijun |
Report |
Oct 31, 2018 |
5014 |
| Collaboration To Develop Blood Stem Cell Replacement Product. |
|
|
Oct 29, 2018 |
186 |
| Orphan Drug Designation For Treatment Of Stem Cell Transplant-Related Disorder. |
|
|
Oct 29, 2018 |
365 |
| Collaboration To Develop Blood Stem Cell Replacement Product. |
|
|
Oct 29, 2018 |
187 |
| Orphan Drug Designation For Treatment Of Stem Cell Transplant-Related Disorder. |
|
|
Oct 29, 2018 |
365 |
| Chimerix presents preclinical data showing antiviral activity of Brincidofovir. |
|
|
Oct 28, 2018 |
163 |
| Omeros granted FDA Orphan Drug Designation for OMS721. |
|
|
Oct 23, 2018 |
164 |
| Bioinformatics Tool Can ID Source of Bloodstream Pathogens; Classically non-enteric pathogens identified in gut microbiome, challenging origin of these infections. |
|
|
Oct 19, 2018 |
194 |
| First Patient Dosed in Phase 2 Clinical Trial of MaaT Pharma Lead Product MaaT013, a First-in-class Biotherapeutic to Treat Acute GvHD. |
|
|
Oct 12, 2018 |
450 |
| Chimerix study shows correlation of Adv burden, allo-HCT recipients mortality. |
|
|
Oct 4, 2018 |
107 |
| Can Therapeutically-Rational Exchange (T-REX) of Thalassemic Red Blood Cells Improve the Clinical Course of Plasmodium falciparum Malaria? |
Jajosky, Ryan Philip; Jajosky, Audrey N.; Jajosky, Philip G. |
|
Oct 1, 2018 |
822 |
| Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies. |
|
|
Sep 30, 2018 |
797 |
| CytoSen Therapeutics Receives FDA's Favorable Response to Pre-IND Meeting Package for Phase 2 Study in AML. |
|
|
Sep 28, 2018 |
455 |
| Pluristem PLX cell therapy granted FDA Orphan Drug Designation. |
|
|
Sep 25, 2018 |
136 |
| Be The Match[R] and Illusionist Jim Munroe Launch #MakeCancerDisappear Public Challenge Today. |
|
|
Sep 20, 2018 |
661 |
| Nine things you should know about blood stem cell donation; As new research finds that two-thirds of Brits wouldn't donate their stem cells, LISA SALMON asks experts to dispel some of the most common myths. |
|
|
Sep 19, 2018 |
979 |
| Cambodian Thalassemia kids given new lives after Indian help. |
|
|
Sep 17, 2018 |
920 |
| Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation. |
Huang, Wen-Rong; Liu, Dai-Hong |
Report |
Sep 5, 2018 |
6001 |
| Bluebird Bio presents updated data on Phase 2 Starbeam study of Lenti-D. |
|
|
Sep 5, 2018 |
368 |
